CIC
Cornercap Investment Counsel Portfolio holdings
AUM
$203M
1-Year Est. Return
17.67%
This Fund
S&P 500
1 Year Est. Return
+17.67%
AUM
$201M
AUM Growth
+$8.84M
(+4.6%)
Holding
157
Top Buys
| 1 | +$1.65M | |
| 2 | +$1.61M | |
| 3 | +$1.57M | |
| 4 |
Blackstone
BX
|
+$1.57M |
| 5 |
Colgate-Palmolive
CL
|
+$1.56M |
Top Sells
| 1 | +$1.3M | |
| 2 | +$1.08M | |
| 3 | +$1.01M | |
| 4 |
Biogen
BIIB
|
+$991K |
| 5 |
Target
TGT
|
+$944K |
Sector Composition
| 1 | Financials | 20.73% |
| 2 | Technology | 16.06% |
| 3 | Healthcare | 14.09% |
| 4 | Industrials | 10.66% |
| 5 | Consumer Staples | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Neurocrine Biosciences
NBIX
$13.1B
| – | – |
-4,859
|
|
||
|
152
Biogen
BIIB
$27.6B
| – | – |
-7,894
|
|
||
153
Constellation Energy
CEG
$106B
| – | – |
-3,117
|
|
||
154
Applovin
APP
$153B
| – | – |
-2,103
|
|
||
|
155
Target
TGT
$58.9B
| – | – |
-9,570
|
|
||
156
Mid-America Apartment Communities
MAA
$14.7B
| – | – |
-4,364
|
|
||
157
T. Rowe Price
TROW
$21.6B
| – | – |
-13,503
|
|